Orphan Drugs

November 21th, 2017 Moscow, Russia and Pully, Switzerland: Nativa LLC and CarthaGenetics® announce collaboration in North Africa area

Nativa LLC is a full-cycle Russian pharmaceutical company founded in 2010, developing and producing world-class complex medicaments essential for human health. It focuses on oncology, pulmonology, multiple sclerosis and other fields.

CarthaGenetics® is focusing on finding innovative early patients access to medicines for treating unmet needs and is now a pioneer with one of the broadest experience in the field of rare diseases, gene therapies and biosimilars.

For any question concerning this please contact Vladimir A. Mefodovskiy, CDO at Nativa LLC v.mefodovskiy@nativa.pro or Philippe Carteron de Balmont CEO, at CarthaGenetics® phcarteron@carthagenetics.com